Other Viruses Citation List:
May 27 - June 9, 2011
Human Cytomegalovirus
1. Synthesis, Transport and Antiviral Activity of Ala-Ser and Val-Ser Prodrugs of Cidofovir. Peterson, L.W., J.S. Kim, P. Kijek, S. Mitchell, J. Hilfinger, J. Breitenbach, K. Borysko, J.C. Drach, B.A. Kashemirov, and C.E. McKenna. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21641218].
[PubMed]. OV_0527-060911.
Epstein-Barr virus
2. Conjugates of 3alpha-Methoxyserrat-14-En-21beta-Ol (Pj-1) and 3beta-Methoxyserrat-14-En-21beta-Ol (Pj-2) as Cancer Chemopreventive Agents. Tanaka, R., H. Tsujii, T. Yamada, T. Kajimoto, H. Tokuda, T. Arai, N. Suzuki, J. Hasegawa, Y. Hamashima, and M. Node. European Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21620532].
[PubMed]. OV_0527-060911.
3. Arsenic Mediated Disruption of Promyelocytic Leukemia Protein Nuclear Bodies Induces Ganciclovir Susceptibility in Epstein-Barr Positive Epithelial Cells. Sides, M.D., G.J. Block, B. Shan, K.C. Esteves, Z. Lin, E.K. Flemington, and J.A. Lasky. Virology, 2011. [Epub ahead of print]; PMID[21605886].
[PubMed]. OV_0527-060911.
Hepatitis C virus
4. Anti-Ulcer Agent Teprenone Inhibits Hepatitis C Virus Replication: Potential Treatment for Hepatitis C. Ikeda, M., Y. Kawai, K. Mori, M. Yano, K. Abe, G. Nishimura, H. Dansako, Y. Ariumi, T. Wakita, K. Yamamoto, and N. Kato. Liver international : official journal of the International Association for the Study of the Liver, 2011. 31(6): p. 873-882; PMID[21645219].
[PubMed]. OV_0527-060911.
5. Synthesis and Antiviral Activity of Cyclopropyl-Spirocarbocyclic Adenosine, (4r,5s,6r,7r)-4-(6-Amino-9h-Purin-9-Yl)-7-(Hydroxymethyl)Spiro[2.4]Heptane-5,6-Di Ol against Hepatitis C Virus. Gadthula, S., R.K. Rawal, A. Sharon, D. Wu, B. Korba, and C.K. Chu. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21621997].
[PubMed]. OV_0527-060911.
Herpes Simplex virus
6. Synthesis, Crystal Structure, and in Vitro Biological Evaluation of C-6 Pyrimidine Derivatives: New Lead Structures for Monitoring Gene Expression in Vivo. Martic, M., L. Pernot, Y. Westermaier, R. Perozzo, T.G. Kraljevic, S. Kristafor, S. Raic-Malic, L. Scapozza, and S. Ametamey. Nucleosides, nucleotides & nucleic acids, 2011. 30(4): p. 293-315; PMID[21623543].
[PubMed]. OV_0527-060911.
7. Antiviral Activity of Lactobacillus Brevis Towards Herpes Simplex Virus Type 2: Role of Cell Wall Associated Components. Mastromarino, P., F. Cacciotti, A. Masci, and L. Mosca. Anaerobe, 2011. [Epub ahead of print]; PMID[21621625].
[PubMed]. OV_0527-060911.
8. Efficacy of Plant Products against Herpetic Infections. Schnitzler, P. and J. Reichling. HNO, 2011. [Epub ahead of print]; PMID[21607799].
[PubMed]. OV_0527-060911.
Citations from the ISI Web of Knowledge Listings for O.V.
9. Lysosomotropic Agents as HCV Entry Inhibitors. Ashfaq, U.A., T. Javed, S. Rehman, Z. Nawaz, and S. Riazuddin. Virology Journal, 2011. 8; ISI[000290446300001].
[WOS]. OV_0527-060911.
10. A Reporter System for Epstein-Barr Virus (EBV) Lytic Replication: Anti-EBVActivity of the Broad Anti-Herpesviral Drug Artesunate. Auerochs, S., K. Korn, and M. Marschall. Journal of Virological Methods, 2011. 173(2): p. 334-339; ISI[000290836400025].
[WOS]. OV_0527-060911.
11. The Discovery and Structure-Activity Relationships of Pyrano 3,4-B Indole-Based Inhibitors of Hepatitis C Virus Ns5b Polymerase. Jackson, R.W., M.G. LaPorte, T. Herbertz, T.L. Draper, J.A. Gaboury, S.R. Rippin, R. Patel, S.K. Chunduru, C.A. Benetatos, D.C. Young, C.J. Burns, and S.M. Condon. Bioorganic & Medicinal Chemistry Letters, 2011. 21(11): p. 3227-3231; ISI[000290708300007].
[WOS]. OV_0527-060911.
12. Discovery of Novel HCV Polymerase Inhibitors Using Pharmacophore-Based Virtual Screening. Kim, N.D., H. Chun, S.J. Park, J.W. Yang, J.W. Kim, and S.K. Ahn. Bioorganic & Medicinal Chemistry Letters, 2011. 21(11): p. 3329-3334; ISI[000290708300028].
[WOS]. OV_0527-060911.
13. 2-Arylmethylaminomethyl-5,6-Dihydroxychromone Derivatives with Selective Anti-HCV Activity. Park, H.R., K.S. Park, and Y. Chong. Bioorganic & Medicinal Chemistry Letters, 2011. 21(11): p. 3202-3205; ISI[000290708300002].
[WOS]. OV_0527-060911.
14. 2,3-Dihydro-1,2-Diphenyl-Substituted 4h-Pyridinone Derivatives as New Anti Flaviviridae Inhibitors. Peduto, A., A. Massa, A. Di Mola, P. de Caprariis, P. La Colla, R. Loddo, S. Altamura, G. Maga, and R. Filosa. Chemical Biology & Drug Design, 2011. 77(6): p. 441-449; ISI[000290587700005].
[WOS]. OV_0527-060911.
15. Syntheses and Initial Evaluation of a Series of Indolo-Fused Heterocyclic Inhibitors of the Polymerase Enzyme (Ns5b) of the Hepatitis C Virus. Zheng, X.F., T.W. Hudyma, S.W. Martin, C. Bergstrom, M. Ding, F. He, J. Romine, M.A. Poss, J.F. Kadow, C.H. Chang, J. Wan, M.R. Witmer, P. Morin, D.M. Camac, S. Sheriff, B.R. Beno, K.L. Rigat, Y.K. Wang, R. Fridell, J. Lemm, D. Qiu, M.P. Liu, S. Voss, L. Pelosi, S.B. Roberts, M. Gao, J. Knipe, and R.G. Gentles. Bioorganic & Medicinal Chemistry Letters, 2011. 21(10): p. 2925-2929; ISI[000290024200027].
[WOS]. OV_0527-060911.